Dr. Maureen Kennedy, assistant professor of Epidemiology, received her Dr.P.H. (2011) and M.S. (2004) in Epidemiology from New York Medical College School of Health Sciences and Practice. She also holds undergraduate degrees in Medical Technology and Biology with a minor in Microbiology. Shortly after 9-11and prior to becoming a full time faculty at New York Medical College, Dr. Kennedy played a significant role in establishing, validating, and managing a BSL3 Bio-Defense laboratory designed to serve and protect New York State’s Lower Hudson Valley Region. Following the implementation of the Affordable Care Act, her epidemiological skills were put to further use while working in health outcomes research analyzing chronic diseases and evaluating health services utilization.
Dr. Kennedy’s research and services while at New York Medical College are extensive. She has engaged in successful analytical epidemiological research in infectious diseases including accurately determining the origin of a nosocomial bacterial outbreak and served as a lead analyst to quantitatively identify and measure specific risks associated with bacterial transmission amongst intravenous drug users residing in a NYC community. She assisted with planning COVID-19 screening of employees, personnel, and students at New York Medical College. Dr. Kennedy has served as an analyst and consultant serving a Westchester community project evaluating adolescent substance use, which was funded by the Office of National Drug Control Policy. She is also currently an improvement program evaluator for a victim’s assistant program located in New York.
Dr. Kennedy is a member and supporter of the American Public Health Association (APHA) and the New York State Public Health Association (NYSPHA).
In terms of research, Dr. Drugge has over 15 peer-reviewed, scientific articles in academic journals such as Circulation Research,Science, American Journal of Physiology, Journal of Pharmacological and Experimental Therapeutics, and Journal of the American Academy of Dermatology and has presented her research at national meetings, including American Academy of Dermatology (AAD), Federation of American Societies for Experimental Biology (FASEB), American Heart Association Scientific Session (AHA), and the Association for Research in Vision and Ophthalmology (ARVO). Her early work in cardiac electrophysiology focused on the mechanism by which sympathetic innervation regulates the chronotropic response of cultured cardiac myocytes. Her post-doctoral fellowship, under the direction of John C. McGiff, MD, explored regulatory mechanisms related to arachidonic acid in cultured renal and corneal cells with unique transport properties. Dr. Elizabeth Drugge, Assistant Professor of Epidemiology, received her Ph.D. in Pharmacology from Columbia College of Physicians & Surgeons following a B.A. in Science, Technology and Society from Cornell University. She also received an M.P.H in Epidemiology from New York Medical College (NYMC) School of Health Sciences and Practice, and a post-doctoral fellowship in Pharmacology at NYMC. Subsequently, she transitioned to independent research in dermatology where she worked on the development, implementation, and assessment of a novel system for automated skin cancer detection. During this time, she mentored medical students on research projects, including a DeBakey scholar, and contributed to clinical research and public health endeavors related to skin cancer screening. In addition, she held adjunct appointments in the NYMC Departments of Epidemiology and Physical Therapy, in the School of Health Sciences and Practice, and the Department of Pharmacology, in the School of Basic Medical Sciences, before joining the Epidemiology Division of the Department of Public Health.
Dr. Drugge’s current research interests include identifying blood pressure regulatory mechanisms that contribute to salt-sensitive hypertension related to gender and race using data from the DASH-Sodium Clinical Trial. She also continues to work on several research projects related to skin cancer detection using innovative technologies and systems of care to identify associations between risk factors and outcomes. The goal of these studies is to eliminate access barriers, address disease disparities, and deliver telehealth services.
As a member of the American Heart Association, American Academy of Dermatology, and American Public Health Association, Dr. Drugge continues to explore and contribute to the advancement of evidence-based research. She is most rewarded by her work with students of all disciplines, supporting them to develop the skills and confidence to impact the world of healthcare that lies ahead.
Drugge’s Researchgate Website:
Drugge’s Complete List of Published Work in PubMed: